H C Diener, R Bernstein, K Butcher, B Campbell, G Cloud, A Davalos, S Davis, J M Ferro, M Grond, D Krieger, G Ntaios, A Slowik, E Touzé
Systemic thrombolysis with rt-PA is contraindicated in patients with acute ischemic stroke anticoagulated with dabigatran. This expert opinion provides guidance on the use of the specific reversal agent idarucizumab followed by rt-PA and/or thrombectomy in patients with ischemic stroke pre-treated with dabigatran. The use of idarucizumab followed by rt-PA is covered by the label of both drugs.
September 30, 2016: International Journal of Stroke: Official Journal of the International Stroke Society